Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Oct 31, 2025 | (FY)Jul 31, 2025 | (Q4)Jul 31, 2025 | (Q3)Apr 30, 2025 | (Q2)Jan 31, 2025 | (Q1)Oct 31, 2024 | (FY)Jul 31, 2024 | (Q4)Jul 31, 2024 | (Q3)Apr 30, 2024 | (Q2)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -345.15%-154.72K | 89.75%-58.13K | -137.90%-29.25K | 69.75%-45.08K | 92.12%-46.92K | -37.05%63.11K | -0.46%-566.95K | 160.67%77.17K | 20.45%-149K | -1,017.48%-595.38K |
| Net income from continuing operations | 159.42%93.63K | -118.85%-1.28M | -652.11%-792.38K | 18.77%-156.21K | -4.72%-176.59K | -31.48%-157.56K | 3.17%-586.14K | 52.65%-105.36K | -138.27%-192.31K | -192.26%-168.64K |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | ---42.42K | ---- | ---- | ---- |
| Asset impairment expenditure | ---- | --705.58K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Remuneration paid in stock | --0 | --34.87K | --0 | --0 | --0 | --34.87K | --0 | ---- | ---- | ---- |
| Deferred tax | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Other non cashItems | -526.08%-215.57K | 8.53%177.26K | -99.99%2 | 62.44%73.47K | 18.98%53.2K | 34.76%50.59K | -24.46%163.33K | -84.31%35.85K | 348.15%45.23K | 438.24%44.71K |
| Change In working capital | -124.24%-32.78K | 401.74%306.91K | -69.56%57.56K | 2,065.66%37.66K | 116.22%76.48K | -25.93%135.22K | 37.51%-101.72K | 256.61%189.09K | 97.83%-1.92K | -447.13%-471.45K |
| -Change in receivables | -102.01%-4.39K | 265.76%253.32K | 99.61%-73 | 648.04%20.57K | 112.75%15.07K | 1,271.34%217.75K | -86.61%-152.83K | 35.65%-18.78K | 106.31%2.75K | -956.80%-118.2K |
| -Change in prepaid assets | -46.83%-12.86K | 34.10%-257 | 972.34%4.92K | -134.02%-1.27K | 10.71%4.85K | -10.40%-8.76K | 66.38%-390 | -243.90%-564 | 2.45%3.73K | 1.84%4.38K |
| -Change in payables and accrued expense | 85.70%-15.54K | 4.56%53.85K | -74.71%52.71K | 318.74%18.36K | 125.56%91.42K | -151.96%-108.64K | 164.62%51.5K | 328.07%208.44K | 82.66%-8.39K | -403.80%-357.63K |
| -Change in other working capital | ---- | ---- | ---- | ---- | ---- | --34.87K | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -345.14%-154.72K | 89.75%-58.13K | -137.90%-29.24K | 69.75%-45.08K | 92.12%-46.92K | -37.05%63.11K | -0.46%-566.95K | 160.67%77.17K | 20.45%-149K | -1,017.48%-595.38K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -2,284.29%-1.67M | 107.18%37.19K | 90.57%-9.49K | -70.08%76.14K | 115.99%40.68K | 83.18%-70.14K | 58.08%-517.68K | 89.50%-100.65K | 318.24%254.43K | -56.93%-254.44K |
| Net PPE purchase and sale | -134.69%-17.3K | 94.50%-87.82K | 95.94%-9.49K | 31.79%-43.86K | 89.54%-84.32K | 110.12%49.86K | -177.86%-1.6M | -41,973.12%-233.65K | 69.66%-64.3K | -184.36%-806.44K |
| Net investment purchase and sale | -1,279.17%-1.66M | -82.88%125K | --0 | 20.00%120K | -76.42%125K | ---120K | 173.00%730K | 110.00%100K | --100K | --530K |
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | 2.80%349.38K | -18.66%33K | 129.37%218.73K | -81.89%22K |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -2,284.29%-1.67M | 107.18%37.19K | 90.57%-9.49K | -70.07%76.14K | 115.99%40.68K | 83.18%-70.14K | 58.08%-517.68K | 89.50%-100.65K | 318.24%254.43K | -56.93%-254.44K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 2.23M | 0 | 0 | 0 | 0 | 0 | -109.10%-206.56K | 0 | -183.42%-145.17K | -101.60%-37.83K |
| Net issuance payments of debt | ---31.25K | --0 | --0 | --0 | --0 | --0 | 4.43%-206.56K | --0 | -60.02%-145.17K | 36.88%-37.83K |
| Net common stock issuance | --2.3M | ---- | ---- | ---- | --0 | --0 | --0 | --0 | --0 | --0 |
| Net other financing activities | ---37.98K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --2.23M | --0 | --0 | --0 | --0 | --0 | -109.10%-206.56K | --0 | -183.42%-145.17K | -101.60%-37.83K |
| Net cash flow | ||||||||||
| Beginning cash position | -19.19%88.22K | -92.20%109.17K | -4.29%126.96K | -44.37%95.9K | -90.36%102.14K | -92.20%109.17K | 50.63%1.4M | -94.73%132.65K | -93.99%172.39K | 75.09%1.06M |
| Current changes in cash | 5,848.21%403.75K | 98.38%-20.95K | -64.95%-38.74K | 178.15%31.06K | 99.30%-6.24K | 97.94%-7.02K | -374.32%-1.29M | 97.89%-23.48K | 88.81%-39.74K | -139.20%-887.64K |
| End cash Position | 381.66%491.97K | -19.19%88.22K | -19.19%88.22K | -4.29%126.96K | -44.37%95.9K | -90.36%102.14K | -92.20%109.17K | -92.20%109.17K | -94.73%132.65K | -93.99%172.39K |
| Free cash from | -409.41%-172.02K | 93.26%-145.95K | 65.75%-38.74K | 65.35%-88.94K | 94.73%-73.86K | 114.17%55.59K | -89.98%-2.16M | 10.69%-113.11K | 35.71%-256.67K | -540.97%-1.4M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.